Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
International Journal of Cancer|March 12, 2019
Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptorNicola Tumino, Stefania Martini, Enrico Munari, et al.Cancer Immunology, Immunotherapy : CII|November 30, 2022
Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancersPiera Filomena Fiore, Anna Laura Di Pace, Libenzio Adrian Conti, et al.Cancers|January 13, 2021
Wilms' Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and MacrophagesPiera Filomena Fiore, Paola Vacca, Nicola Tumino, et al.Plos One|July 11, 2015
Vγ9Vδ2 T-Cell Polyfunctionality Is Differently Modulated in HAART-Treated HIV Patients according to CD4 T-Cell CountRita Casetti, Gabriele De Simone, Alessandra Sacchi, et al.Frontiers in Immunology|May 23, 2019
Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell KillingTiziano Ingegnere, Francesca Romana Mariotti, Andrea Pelosi, et al.Oncoimmunology|February 7, 2019
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expressionFrancesca R Mariotti, Stefania Petrini, Tiziano Ingegnere, et al.The Journal of Allergy and Clinical Immunology|May 18, 2020
Glucocorticoids and the cytokines IL-12, IL-15, and IL-18 present in the tumor microenvironment induce PD-1 expression on human natural killer cellsLinda Quatrini, Paola Vacca, Nicola Tumino, et al.International Journal of Cancer|December 5, 2022
The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activityNicola Tumino, Carina B Nava Lauson, Silvia Tiberti, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 19, 2017
HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic InfectionRita Casetti, Carmela Pinnetti, Alessandra Sacchi, et al.Journal of Hematology & Oncology|November 13, 2021
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastomaNicola Tumino, Gerrit Weber, Francesca Besi, et al.Pageof 3